Kardioselektivnyy beta-adrenoblokator bisoprolol v lechenii arterial'noy gipertenzii

The article is devoted to one of the main groups of drugs used in cardiology, - β-blockers (BB), in particular bisoprolol. Indications and contraindications for the use of BB, the principles of transition from monotherapy to combined therapy of arterial hypertension (AH) are presented. Particular attention is paid to the drug Bisogamma ®, a cardioselective BB without intrinsic sympathomimetic activity, which acts selectively on β-adrenergic receptors, and its antihypertensive effect is based on the reduction of cardiac output, inhibition of renin secretion by the kidneys. A multicomponent antihypertensive effect of Bisogamma® against the background of metabolic neutrality allows to recommend this cardioselective BB for the treatment of hypertensive patients with with obesity, disorders of blood lipid and glycemic profiles, and with chronic obstructive pulmonary disease.

arterial hypertension, antihypertensive agents, β-adrenoblockers, bisoprolol, Bisogamma